Cargando…

Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People

Although transgender women have been included in HIV prevention pre-exposure prophylaxis studies, no pre-exposure prophylaxis study has focused exclusively on transgender persons. Drawing on the cardinal principles of ethics espoused in the Belmont Report, this work highlights, among other issues, t...

Descripción completa

Detalles Bibliográficos
Autor principal: Singh, Jerome Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969064/
https://www.ncbi.nlm.nih.gov/pubmed/27429192
http://dx.doi.org/10.1097/QAI.0000000000001089
_version_ 1782445738795466752
author Singh, Jerome Amir
author_facet Singh, Jerome Amir
author_sort Singh, Jerome Amir
collection PubMed
description Although transgender women have been included in HIV prevention pre-exposure prophylaxis studies, no pre-exposure prophylaxis study has focused exclusively on transgender persons. Drawing on the cardinal principles of ethics espoused in the Belmont Report, this work highlights, among other issues, that (1) the principle of Justice requires the HIV prevention field to focus exclusively on transgender persons, (2) the disclosure of potential study-related risks to study participants demonstrates Respect for Persons, and (3) devising risk mitigation plans, optimizing a proposed study's standard of care, and the provision of ancillary care satisfy the principle of Beneficence.
format Online
Article
Text
id pubmed-4969064
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-49690642016-08-17 Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People Singh, Jerome Amir J Acquir Immune Defic Syndr Supplement Article Although transgender women have been included in HIV prevention pre-exposure prophylaxis studies, no pre-exposure prophylaxis study has focused exclusively on transgender persons. Drawing on the cardinal principles of ethics espoused in the Belmont Report, this work highlights, among other issues, that (1) the principle of Justice requires the HIV prevention field to focus exclusively on transgender persons, (2) the disclosure of potential study-related risks to study participants demonstrates Respect for Persons, and (3) devising risk mitigation plans, optimizing a proposed study's standard of care, and the provision of ancillary care satisfy the principle of Beneficence. JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-08-15 2016-07-18 /pmc/articles/PMC4969064/ /pubmed/27429192 http://dx.doi.org/10.1097/QAI.0000000000001089 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Supplement Article
Singh, Jerome Amir
Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People
title Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People
title_full Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People
title_fullStr Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People
title_full_unstemmed Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People
title_short Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People
title_sort ethical issues to consider in the design of hiv prevention trials involving transgender people
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969064/
https://www.ncbi.nlm.nih.gov/pubmed/27429192
http://dx.doi.org/10.1097/QAI.0000000000001089
work_keys_str_mv AT singhjeromeamir ethicalissuestoconsiderinthedesignofhivpreventiontrialsinvolvingtransgenderpeople